p.s. My cursory, kneejerk reaction to the fungal-infection thesis for AD was skepticism (www.siliconinvestor.com/readmsg.aspx?msgid=30293630 ).
Thanks for the links. Is the next step to test the fungal-infection thesis trials of anti-fungal drugs in AD patients? Or do these not penetrate the BBB so of no use?